Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Market Data
|
People
|
Events
|
Multimedia
|
Science Abstracts
|
Pfizer to bolster rare disease portfolio with FoldRx acquisition
02 September 2010
Pfizer has reiterated its commitment to developing an orphan and rare diseases franchise by acquiring the private US company FoldRx Pharmaceuticals. The two ...
Relief for Dendreon on upcoming US Medicare coverage meeting on Provenge
02 September 2010
The US agency that runs Medicare – the Centers for Medicare and Medicaid Services (CMS) - has scheduled a 17 November advisory panel meeting to consider ...
Deal with Ono the first for Concordia's novel Ras inhibitor
02 September 2010
Ono Pharmaceutical has acquired exclusive development and commercialisation rights in Japan to Concordia Pharmaceuticals' direct Ras inhibitor salirasib, which ...
Addex makes plans to move mGluR2 antagonist into clinical trials for Alzheimer's disease
02 September 2010
Addex has announced plans to move an mGluR2 antagonist into Phase I trials for Alzheimer's disease (AD) in around a year. "We are currently in late-stage ...
 
Index appoints Johnson partner
02 September 2010
Index Ventures, the global high tech venture capitalist, has appointed Dr Kevin Johnson as a life sciences partner to enhance its push into developing asset-centric investment strategy. Dr Johnson, ...
New investor leads Celator's $20 million series D
02 September 2010
Celator Pharmaceuticals has raised $20 million in a series D round led by new investor Thomas, McNerney & Partners. Alex Zisson , a partner at the venture capital firm, will join Celator's ...
Scottish biotech companies combine
02 September 2010
Two Scottish university spin-out companies, ImmunoSolv and Grampian BioConsultants (GBC), have merged to combine their expertise in immunology and immuno-technology to avoid becoming a "one-trick ...
Henderson Morley files notice of administration
02 September 2010
The small UK biotechnology firm Henderson Morley has filed a notice of intention to call in the administrators following its failure to secure the divestment of its ICVT (Ionic Contra Viral Therapy) ...
 
ThromboGenics' microplasmin positive in second Phase III trial
02 September 2010
ThromboGenic's microplasmin met its primary endpoint – resolution of vitromacular adhesion (VMA) – in patients with the eye disease. The study results, presented at the American Society of Retina ...
Xeloda filed in Japan for additional gastric cancer use
02 September 2010
Roche's Japanese subsidiary, Chugai , has made an approval filing for Xeloda (capecitabine) for the treatment of advanced or refractory gastric cancer in patients who are not candidates for curative ...
Japan to subsidise Takeda's cell cultured flu vaccine R&D
02 September 2010
The Japanese government is to provide a multi-million dollar subsidy to the country's largest pharma company for the development of cell cultured vaccines for pandemic influenza. Following an ...
BMS/Pfizer's apixaban emerges as a strong anti-coagulation contender
01 September 2010
Bristol-Myers Squibb's apixaban beat aspirin (acetylsalicylic acid) for the prevention of venous thromboembolism (VTE) in patients at high-risk of atrial fibrillation (AF) who were unable to take ...
 
India throws rule book at 'superbug' scientists
02 September 2010
Indian physicians who were involved in the controversial "superbug" NDM-1 study that was published in Lancet Infectious Diseases last month have been asked to confirm whether they followed various ...
US appeals court upholds Evista patents through 2014, blocking Teva generic
02 September 2010
A federal appeals court has affirmed a lower court ruling that Lilly's method-of-use patents for its osteoporosis drug Evista (raloxifene) are valid until 2014, blocking an attempt by Teva ...
New Zealand expects savings followingfunding decision for Dr Reddy's quetiapine
02 September 2010
New Zealand expects to save NZ$24 million ($17.1 million) over the next five years following price reductions for certain antipsychotic drugs, said Pharmac , the country's pharmaceutical management ...
Czech agency identifies drugs facing December sunset clause
01 September 2010
SÚKL , the Czech State Institute for Drug Control, has issued a list of medicines that might be subject to a 31 December 2010 sunset clause that will invalidate their marketing authorisations based ...
 
PEOPLE
New appointment at King Pharmaceuticals King Pharmaceuticals (US) has appointed Jeffrey Bailey chief commercial officer. He will be ...
New COO at Millennium Laboratories Millennium Laboratories (US), a provider of therapeutic drug monitoring and education to physicians ...
One Nucleus appoints new director One Nucleus, a UK-based not-for-profit membership organisation for international life science and ...
>> More People News...

EXPERT VIEW
Asia Beat: Debate drags on as Taiwan gets its NHI house in order
01 September 2010
Ian Haydock
Taiwan's efforts to reform its financially struggling national health insurance (NHI) scheme go ...

2010 Scrip 100 - Mixed fortunes on the R&D front
23 August 2010

Continued problems with anti-obesity drugs, more measures designed to improve R&D efficiency, and ...

2010 Scrip 100 - Pharma muscles into emerging markets with M&A
23 August 2010

This year has seen many firms facing patent expiries on core revenue generators. The current ...

2010 Scrip 100 - Changes pharma can believe in?
23 August 2010

Ian Schofield picks some of the most significant developments in the health policy and regulation ...

MULTIMEDIA
Scrip 100: Trends driving pharma in 2010-2011 01 September 2010

Get the Flash Player to see this player.

AstraZeneca makes a narrow escape from UK Seroquel probe
20 August 2010
Elizabeth Sukkar
AstraZeneca's blockbuster atypical antipsychotic Seroquel (quetiapine) has been in the news quite a ...

Calling German and Spanish Physicists: the EMA Needs You
13 July 2010
Maureen Kenny
German or Spanish physicists hoping for a career change involving a move to London at the end of ...

GW high on pipeline of cannabis extracts
23 August 2010
Katie McQue
GW Pharma has enjoyed recent success with its cannabinoid extract product Sativex (nabiximols), ...

Scrip's CPhI, ICSE, P-MEC and BioPh Show Preview
18 August 2010
CPhl Worldwide - with ICSE, P-MEC and BioPh - makes its return to Paris at the popular Paris - Nord ...

EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm